Clinical Trial 54256

Pearland, TX 77584


The purpose of this study is to obtain information on the efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD).  The sponsor is Chiesi Farmaceutici.



Males and females aged 40 years with written informed consent obtained prior to any study-related procedure.

Subjects with an established diagnosis of COPD

Current smokers or ex-smokers who quit smoking at least 6

months prior to screening visit,

Qualified Participants May Receive:

You will be paid $70 per completed visit. You will be paid following each completed visit. 

Available At:

LinQ Research, LLC
11021 Shadow Creek Parkway, Suite 102
Pearland, TX 77584
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.